Charlotte Douard

Health Tech Business Developer at SATT Ouest Valorisation
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Greater Rennes Metropolitan Area, FR
Languages
  • Anglais -

Topline Score

Bio

Generated by
Topline AI

5.0

/5.0
/ Based on 1 ratings
  • (1)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

You need to have a working account to view this content. Click here to join now
Aurélie Bineau

Charlotte Douard travaille depuis 2010 au sein de notre cellule de valorisation de l'Université de Nantes. C'est une personne professionnelle très investie et autonome qui s'est intégrée très facilement et rapidement. Charlotte a su mesurer les enjeux de la valorisation et a mené à bien la projet européen Sharebiotech.

0

/5.0
/ Based on 0 ratings
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

No reviews to display There are currently no reviews available.
You need to have a working account to view this content. Click here to join now

Credentials

  • CAPI
    INPI France
    Jul, 2017
    - Sep, 2024

Experience

  • SATT Ouest Valorisation
    • France
    • Consumer Services
    • 1 - 100 Employee
    • Health Tech Business Developer
      • Jan 2021 - Present

      - Negotiation of technology transfer licences in the sector of Health Tech- Strategy definition for the promotion and marketing of Health Tech innovative technologies & skills- Development of Health industry relations- Health Tech market needs scouting

    • Health Technology Transfer Manager - Medical devices, Biotech
      • Nov 2017 - Dec 2020

      - Detection, analysis and projects evaluation (~30 /year)- Intellectual property strategies definition (filing of ~10 softwares and 4 patents /year)- Definition of economic & market access strategies- Setting up of investment programmes (8 for ~2 M€)- Since June 2020: Medical Device Start-up creation project leaderLeading actions to prepare start-up incorporation and fund-raising (regulatory analysis, prototyping and industrialization, BP, BM canvas, value proposition...)

    • Technology Core facilities Business Developer
      • May 2013 - Oct 2017

      MISSIONSupport of more than 60 R&D core facilities from academic research organizations (Universities, Hospitals, Engineering Schools) of Bretagne and Pays de la Loire regions: structuring services offers, scientific communication and marketing, cost calculation, client prospection… OUEST VALORISATIONOuest Valorisation is a Société d’Accélération du Transfert de Technologies or Technology Transfer Acceleration Company – TTO.Its mission is to add value to the results produced by public research laboratories, in Brittany and Pays de la Loire, and to offer socio-economic actors attractive innovation resources.Ouest Valorisation funds and assists technologies to make them attractive for industrial companies, taking on technological and financial risks inherent to the projects (70 MEuro budget). Ouest Valorisation therefore enable existing companies or startup companies to access public research inventions more quickly to convert them into innovative products. Show less

  • Oktoscience
    • France
    • Medical Equipment Manufacturing
    • Project Leader
      • Jan 2021 - Present

      Project leader (porteuse de projet) of the OKTOSCIENCE start-up project, which aims to create patient-specific closed-loop intelligent neuromodulation devices. Project leader (porteuse de projet) of the OKTOSCIENCE start-up project, which aims to create patient-specific closed-loop intelligent neuromodulation devices.

  • University of Nantes
    • France
    • 1 - 100 Employee
    • ShareBiotech European Project Manager
      • Dec 2010 - Jan 2013

      10 Partners, 4 Countries, ERDF funds ShareBiotech project objective: improve access of companies to academic technological core facilities in the field of life sciences. My activities: - Audit of technological core facilities from the Biogenouest network. - Coordination of consulting studies (Competitive benchnmarking, commercial prospection, communication consultants). - Communication : press, organisation of events. - Financial management (300 000 €): provisional expenses, follow up, execution reports (ERDF), procurement rules, etc. Show less

  • ID2 Santé
    • ShareBiotech European Project Manager
      • Sep 2010 - Nov 2010

      Interview of 56 research groups and companies using cutting edge techniques in the field of life sciences: - Construction of a database of qualified contacts. - Appointments scheduling. - English summary of interviews. Interview of 56 research groups and companies using cutting edge techniques in the field of life sciences: - Construction of a database of qualified contacts. - Appointments scheduling. - English summary of interviews.

  • INSERM
    • France
    • Research Services
    • 700 & Above Employee
    • PhD in Virology
      • Oct 2005 - Dec 2009

      Analysis of Hepatitis B virus entry mechanism : Identification of a new infectivity determinant. Scientific expertise in cellular biology and virology. - Cell culture techniques (in P3 laboratory), viral infection, transfection (electroporation, lipides). - Molecular biology techniques (mutation of viral proteins, quantification of viral particles by Q-PCR). - Development of new protocols. - Scientific publications and International Symposium (listed hereafter). Publications : Entrée du virus de l’hépatite B Lepère-Douard C et Gripon P. Virologie. Volume 14, Numéro 4, 269-84, juillet-août 2010, revue The first transmembrane domain of the hepatitis B virus large envelope protein is crucial for infectivity Lepère-Douard C, Trotard M, Le Seyec J, Gripon P. J Virol. 2009 Nov ; 83(22):11819-29. Kinases required in hepatitis C virus entry and replication highlighted by small interference RNA screening Trotard M, Lepère-Douard C, Régeard M, Piquet-Pellorce C, Lavillette D, Cosset F L, Gripon P et Le Seyec J. FASEB J. 2009 Nov ; 23(11):3780-9. Entry of pseudotyped hepatitis C virus into primary human hepatocytes depends on the scavenger class B type I receptor Régeard M, Trotard M, Lepère C, Gripon P, Le Seyec J. J Viral Hepat. 2008 Dec ; 15(12):865-70. The translocation motif of hepatitis B virus envelope proteins is dispensable for infectivity Lepère C, Régeard M, Le Seyec J, Gripon P. J Virol. 2007 Jul ; 81(14):7816-8. Recent contributions of in vitro models to our understanding of hepatitis C virus life cycle Régeard M, Lepère C, Trotard M, Gripon P, Le Seyec J. FEBS J. 2007 Sep ; 274(18):4705-18. Review. Show less

  • Université de Rennes 1
    • France
    • Civic and Social Organizations
    • Higher Education Teacher
      • Oct 2005 - Oct 2009

      More than 400 hours of teaching in cell biology to BSC and MSC biology students. More than 400 hours of teaching in cell biology to BSC and MSC biology students.

Education

  • DeepTechFouder program
    Entrepreneurial training
    2020 - 2021
  • INPI
    CAPI - Intellectual Property Animator Certificate, IP Law
    2016 - 2017
  • Université de Rennes 1
    PhD, Virology
    2005 - 2009
  • Université de Rennes 1
    MSC, Health, Genomics, Molecular and Cell Biology
    2003 - 2005
  • Université de Rennes 1
    BSC, Cell biology and Physiology
    2002 - 2003

Community

You need to have a working account to view this content. Click here to join now